These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prospects for gene therapy in Parkinson's disease. Freese A; Stern M; Kaplitt MG; O'Connor WM; Abbey MV; O'Connor MJ; During MJ Mov Disord; 1996 Sep; 11(5):469-88. PubMed ID: 8866488 [TBL] [Abstract][Full Text] [Related]
5. The need for regulatable vectors for gene therapy for Parkinson's disease. Cress DE Exp Neurol; 2008 Jan; 209(1):30-3. PubMed ID: 17942096 [TBL] [Abstract][Full Text] [Related]
6. Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease. Bowers WJ; Howard DF; Federoff HJ Exp Neurol; 1997 Mar; 144(1):58-68. PubMed ID: 9126153 [TBL] [Abstract][Full Text] [Related]
7. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
8. Current development of adeno-associated viral vectors. Romano G Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103 [TBL] [Abstract][Full Text] [Related]
9. Gene therapeutic strategies for neurodegenerative diseases. Baekelandt V; De Strooper B; Nuttin B; Debyser Z Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757 [TBL] [Abstract][Full Text] [Related]
10. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Kügler S; Kilic E; Bähr M Gene Ther; 2003 Feb; 10(4):337-47. PubMed ID: 12595892 [TBL] [Abstract][Full Text] [Related]
12. [Gene therapy for Parkinson's disease]. Muramatsu S Brain Nerve; 2007 Apr; 59(4):425-30. PubMed ID: 17447529 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus for neurodegenerative diseases: in vivo strategies and ex vivo gene therapy using human neural progenitors. Sabaté O; Barkats M; Buc-Caron MH; Castel-Barthe MN; Finiels F; Horellou P; Revah F; Mallet J Clin Neurosci; 1995-1996; 3(5):317-21. PubMed ID: 8914799 [TBL] [Abstract][Full Text] [Related]
14. [AAV vector-mediated gene transfer and its application to the nervous system]. Ozawa K Rinsho Shinkeigaku; 2003 Nov; 43(11):835-8. PubMed ID: 15152479 [TBL] [Abstract][Full Text] [Related]
15. Development of an HSV-based vector for the treatment of Parkinson's disease. Fink DJ; Poliani PL; Oligino T; Krisky DM; Goins WF; Glorioso JC Exp Neurol; 1997 Mar; 144(1):103-21. PubMed ID: 9126159 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer in canine eyes: a preclinical study for gene therapy of human uveal melanoma. Andrawiss M; Maron A; Beltran W; Opolon P; Connault E; Griscelli F; Yeh P; Perricaudet M; Devauchelle P J Gene Med; 2001; 3(3):228-39. PubMed ID: 11437328 [TBL] [Abstract][Full Text] [Related]
18. Application of ex vivo gene therapy in the treatment of Parkinson's disease. Raymon HK; Thode S; Gage FH Exp Neurol; 1997 Mar; 144(1):82-91. PubMed ID: 9126156 [TBL] [Abstract][Full Text] [Related]
19. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice. Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009 [TBL] [Abstract][Full Text] [Related]
20. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. Capowski EE; Schneider BL; Ebert AD; Seehus CR; Szulc J; Zufferey R; Aebischer P; Svendsen CN J Neurosci Methods; 2007 Jul; 163(2):338-49. PubMed ID: 17397931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]